{{Rsnum
|rsid=3731201
|Gene=CDKN2A
|Chromosome=9
|position=21988897
|Orientation=minus
|GMAF=0.1125
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CDKN2A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 83.2 | 15.0 | 1.8
| HCB | 94.2 | 5.8 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 72.1 | 24.5 | 3.4
| ASW | 67.3 | 32.7 | 0.0
| CHB | 94.2 | 5.8 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 91.8 | 8.2 | 0.0
| LWK | 51.4 | 41.1 | 7.5
| MEX | 84.5 | 15.5 | 0.0
| MKK | 59.6 | 35.9 | 4.5
| TSI | 71.3 | 26.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20384434
|Title=Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}